Skip to Content

  • Search

View Additional Section Content

CALGB 70604 - A Randomized Phase III Study of Standard Dosing versus Longer Dosing Interval of Zoledornic Acid in Metastatic Cancer. (Breast Adenocarcinoma, Prostate Adenocarcinoma, Multiple Myeloma).

Clinical Trial Categories

  • Symptom Management/Bone Metastasis
Contact
The Rosenfeld Cancer Center at 215-481-2402

Location

  • The Rosenfeld Cancer Center

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a Test
Request an Appointment

215-481-EXAM

Clinical Trials Details